MIRNA is a collaborative research network working across nine countries in sub-Saharan Africa and South Asia to strengthen maternal immunisation programmes in readiness for the introduction of new life-saving vaccines which will improve foetal and infant health.
Maternal vaccines protect mothers and infants from life-threatening infectious diseases during the most vulnerable stages of life.
A cross-institutional, cross-country consortium representing key regions in Africa and Asia.
Learn about the work MIRNA have been doing to support maternal immunisation acceleration in LMICs
Subscribe to MIRNA's newsletter and follow updates to stay informed about the latest research and activities.
BioRxiv, 2025 Authors Jerry C. H. Tam, Abbie C. Sibayan, Jeffrey Seow, Carl Graham, Ashwini Kurshan, Blair Merrick, Richard J. Stanton, Katie J. Doores Abstract The rapid development of vaccines against SARS-CoV-2 during the COVID-19 pandemic proved vital in controlling viral spread and reducing ...
In 2024, as part of my ongoing commitment to promoting ethical, equitable, and impactful health solutions, I had the privilege of spearheading two transformative webinars under the Global Health and ...
From February 18–20, 2025, I had the privilege of attending the Southeast Asian Researcher Career Development Workshop held in Bangkok, Thailand, co-organized by the Academy of Medical Sciences (UK) and ...
El 29 de abril de 2025 se realizó en el Hospital Escuela la Sesión Clínica de Investigación titulada "Uso de la inteligencia artificial (IA) en ...
wondering if this group is still active
Linked here you will find the latest Network Newsletter.
The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more
SPEAC’s Special Populations team, in collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, has launched an LSR and meta-analysis tool focused on the safety, effectiveness, and immunogenicity of Chikungunya vaccines Read more
